Morgan Stanley and Tesla Earnings in Focus Along with Fed’s Beige Book

Morgan Stanley (NYSE:MS) and Tesla (NASDAQ:TSLA) are set to report earnings on Wednesday, April 19, 2023. Morgan Stanley, a leading financial services company, will report ahead of the opening bell, while Tesla, a leading electric vehicle maker, will report after the market closes. Both companies’ earnings reports will be closely.

Read More

Netflix Earnings Beat Estimates, But Guidance Falls Short Despite Ad-Supported Tier Launch

Netflix, the leading streaming giant, announced its earnings after the market closed on Tuesday, and the results were mixed. While earnings came in ahead of analysts’ estimates, the guidance fell short of expectations, causing a dip in the stock price. Despite launching its ad-supported tier, which was expected to drive.

Read More

Stock Market Ends on Mixed Note as Technology Sector Saves the Day

The stock market experienced a mixed session on Tuesday, April 18th, with the S&P 500 gaining slightly while the Dow and Nasdaq ended slightly lower. The day’s events followed a choppy session, which saw the S&P 500 eke out slender gains. The overall mixed session can be attributed to the.

Read More

Stock Market Futures Fall as Dow, S&P 500, and Nasdaq 100 Decline

At 06:08 ET (10:08 GMT), the futures contracts for the Dow Jones Industrial Average, S&P 500, and Nasdaq 100 were all down, indicating a decline in the stock market. The Dow futures contract was down 170 points or 0.5%, the S&P 500 futures were down 25 points or 0.6%, and.

Read More

S&P/ASX 200 VIX Falls 4.85% to New 1-Month Low

Introduction The S&P/ASX 200 VIX, which measures the implied volatility of S&P/ASX 200 options, has fallen by 4.85% to reach a new 1-month low. This is an interesting development that has implications for the market. In this article, we will explore what the S&P/ASX 200 VIX is, what this drop.

Read More

Australian Mining Stocks Experience Mixed Results: St Barbara Ltd (ASX:SBM) Takes the Hardest Hit

The Australian stock market had a mixed session, with some mining stocks falling while others held steady. St Barbara Ltd (ASX:SBM) took the biggest hit, falling by over 10%. Meanwhile, Ramelius Resources Ltd (ASX:RMS) and Clinuvel Pharmaceuticals Ltd (ASX:CUV) also experienced losses. St Barbara Ltd (ASX:SBM) was the worst performer.

Read More

ASX Market Update: Resolute Mining and A2 Milk Company See Positive Gains

Resolute Mining Ltd (ASX:RSG) experienced a positive gain of 3.30% or 0.02 points to end at 0.47 in the ASX market. This mining company has been performing well in recent months, with its share prices experiencing a gradual increase since the beginning of the year. One of the key factors.

Read More

Australian Stocks Close Lower Due to Weakness in Energy, Consumer Staples and IT Sectors

The Australian stock market closed lower on Tuesday, with the S&P/ASX 200 index falling by 0.29%. This decline was mainly driven by weakness in the energy, consumer staples, and IT sectors. The Energy sector was the biggest loser, with the S&P/ASX 200 Energy index falling by 1.58%. The Consumer Staples.

Read More

China Mobile considering buyout of HKBN, sparking bidding war

China Mobile, a state-owned telecommunications company, is considering a buyout of Hong Kong’s leading telecoms company, HKBN Ltd. The potential acquisition has sparked a bidding war for the company, which is currently valued at $1 billion. China Mobile sent a request for proposal (RFP) to a small group of banks.

Read More

Stock Futures Show Modest Gains Ahead of Market Open

As investors gear up for a new week of trading, stock futures are showing modest gains. By 7:00pm ET (11:00pm GMT) on Sunday, Dow Jones Futures and S&P 500 Futures were up 0.2% apiece, while Nasdaq 100 Futures gained 0.1%. This positive outlook is following a week of mixed performance,.

Read More

Merck to Acquire Prometheus Biosciences for $10.8 Billion to Strengthen its Presence in Immunology

Introduction Pharmaceutical giant Merck & Co has announced its latest acquisition of California-based biotechnology company, Prometheus Biosciences, for a staggering $10.8 billion. The acquisition will provide Merck & Co with a promising experimental treatment for ulcerative colitis and Crohn’s disease, as well as strengthen its presence in the field of.

Read More

ASX 200 Index Gains 0.2% Ahead of Reserve Bank’s April Meeting Minutes

Introduction The ASX 200 index in Australia rose 0.2% as investors turned their attention towards the upcoming release of the Reserve Bank of Australia’s April meeting minutes. During the meeting, the bank paused its current rate hike cycle, which is expected to have a significant impact on the country’s economy..

Read More